Pharmacist and DTPh
AMA eVoice
AMA eVoice is your regular update on the most important health care issues and recent AMA activities.
Date:
05/22/2009
, Publication:
AMA
, Author:
AMA
http://www.ama-assn.org/ama/pub/news-events/newsletters-journals/ama-evoice-wee
NCPA: Get into politics or get out of pharmacyDate:
05/14/2009
, Publication:
Drug Topics
, Author:
Alaina Scott
http://drugtopics.modernmedicine.com/drugtopics/Associations/NCPA-Get-into-poli
Drug Price : Mail Service and Higher Generic Use Helps Keep Spending in Check,
Countering Brand Drug Price Inflation and Specialty Medication Growth
Date:
05/14/2009
, Publication:
PharmaLive.com
, Author:
PharmaLive.com
http://pharmalive.com/news/index.cfm?articleID=626523&categoryid=9&newsletter=1
Methadone: SAMHSA and FDA Join to Educate the Public on the Safe Use of MethadoneDate:
04/29/2009
, Publication:
FDA News
, Author:
FDA
http://www.fda.gov/bbs/topics/NEWS/2009/NEW02003.html
AMA Launches Twitter Profile to Share News and InformationDate:
04/01/2009
, Publication:
AMA
, Author:
AMA
http://www.ama-assn.org/ama/pub/news-events/news-events/ama-twitter-profile.sht
AMA Unveils Electronic Prescribing Online Learning CenterDate:
04/01/2009
, Publication:
AMA
, Author:
AMA
http://www.ama-assn.org/ama/pub/news-events/news-events/ama-unveils-electronic.
Pfizer Drops Development of 2 Late-stage DrugsDate:
02/24/2009
, Publication:
TherapeuticsDaily.com
, Author:
TherapeuticsDaily.com
http://www.therapeuticsdaily.com/news/article.cfm?contentValue=1889639&contentT
FDA Issues Update to Safety Review on Cholesterol-Lowering Drugs
The U.S. Food and Drug Administration today reaffirmed its position that elevated amounts of low-density lipoprotein (LDL), or “bad cholesterol,” are a risk factor for cardiovascular diseases...
Date:
01/09/2009
, Publication:
FDA
, Author:
FDA
http://www.fda.gov/bbs/topics/NEWS/2009/NEW01939.html
Serious Infections and Neurological Events with Raptiva
Raptiva is an immunosuppressant approved as a once a week injection to treat certain adult patients with moderate to severe plaque psoriasis.
Date:
01/09/2009
, Publication:
Recalls and Safety Alerts
, Author:
FDA
http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/psn/transcript.cfm?show=83#1
Recall of ReliOn Insulin Syringes
Covidien, formerly Tyco Health Care, has recalled one lot of ReliOn disposable insulin syringes because of mislabeling. Some of the U-40 syringes in this lot were mistakenly labeled as U-100 syringes.
Date:
01/09/2009
, Publication:
Recalls and Safety Alerts
, Author:
FDA
http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/psn/transcript.cfm?show=83#2
Previous
Page 1 of 24
Next >
Search returned 238 items.
|
Sponsored Links
Medical Marketing & Media is a monthly
to 14,000 healthcare marketing executives
www.medicalmarketingandmedia.com
This twice-monthly news magazine
reports on all phases of pharmacy
www.drugtopics.com
|